Last updated: June 2026. NAD+ and NMN are marketed for longevity, and the human evidence that either slows aging is limited. NMN is sold as a supplement and is also compounded; NAD+ is usually compounded and given by IV or injection. Neither is an FDA-approved anti-aging drug. Every clinical and regulatory claim links to a primary source.
I ran a gym for a long time. You learn to spot the pitch before the guy finishes his sentence. “This supplement will change your life.” “This machine burns fat while you sleep.” Same energy with NAD+ and NMN. Everybody’s got a spreadsheet showing you the cheapest milligrams per dollar, like that’s the whole story.
I built that spreadsheet too. Cost per gram, ranked cheapest to priciest. Took me about a day to realize I was measuring the wrong thing. Price per milligram tells you what leaves your wallet. It tells you nothing about whether the stuff in the vial matches the label, or whether anybody with a license looked at you before you swallowed or injected it. For something this thin on human evidence, that’s not a minor detail. That’s the whole deal.
So I scrapped the sheet and started over. Here’s the pitch you’ll hear, why most of it is noise, what actually holds up, and who I’d trust with my own money.
The pitch
“Your NAD+ drops as you age, so refill the tank and you’ll feel younger.” That’s the sales copy, more or less, dressed up in different fonts depending on who’s selling.
Part of that is true. NAD+ is a coenzyme your cells need to run energy metabolism, and it’s required for the sirtuins and PARPs tied to DNA repair and aging [P4]. A 2012 study measured it in human tissue from newborns to age 77 and found a steady decline with age, both sexes [P5]. So yes, the tank does run lower. That part isn’t a scam.
Where the pitch gets ahead of the science is the leap from “levels decline” to “refilling it will make you feel or perform better.” That leap is mostly vibes.
Why most of it doesn’t hold up
NMN, the oral compound your body converts into NAD+, has the better evidence of the two, and “better” is a low bar here. The strongest single result is a 2021 Science trial: 250 mg a day for ten weeks improved muscle insulin sensitivity in 25 postmenopausal women with prediabetes [P1]. That’s a real finding. It’s also 25 women, one outcome, one trial. I wouldn’t build a business plan on a sample that small, and you shouldn’t build your anti-aging strategy on it either.
A 2021 trial in amateur runners showed some aerobic measures nudging up, but VO2max, the number that actually matters for fitness, didn’t budge [P2]. The best supporting data comes from nicotinamide riboside, NMN’s cousin, which reliably raised NAD+ in older adults in a 2018 trial and was well tolerated [P3]. Fine, but it’s not NMN, and “raises a biomarker” isn’t the same as “makes you better.”
Now the expensive stuff. IV NAD+ is the priciest route on the market, and it’s also the one with the least behind it. A 2026 systematic review looked for trials testing IV or IM NAD+ for anti-aging and found none eligible [P6]. Zero. The foundational review on the whole subject says it straight: whether restoring NAD+ in aging humans is even safe long-term, let alone beneficial, remains unknown [P4].
Read that twice. The most expensive delivery method has the least evidence. If a trainer sold you the priciest program in the gym with no results to show for it, you’d walk. Same logic applies here.
What actually holds up
Here’s where I landed. If nobody can prove the compound does what the label implies, you’re not buying a guaranteed result. You’re buying a substance that might help, and the only thing that changes the odds in your favor is who’s standing behind it.
That means the cheapest milligrams on the internet are not the best deal, they’re just the cheapest. Cheap with zero accountability isn’t a bargain. It’s a gamble with a shipping label.
So I rebuilt my ranking around what I’d actually call value for something you’re putting in your body:
- Is a clinician involved, evaluating you and writing an actual prescription, or is the price tag just for powder in a bag?
- Is a licensed pharmacy making it under real standards, or is the only proof the seller’s word?
- Can anyone outside the company verify what’s actually in the product, or is it a certificate the seller printed themselves?
- Is the seller straight with you about how thin the evidence is, or are they charging a premium for promises the science doesn’t back?
- Who’s accountable if something’s wrong with the batch? Anybody, or does the relationship end the second the box ships?
Price still matters. It’s just not the only column anymore. A cheap product with zero oversight is bad value. A fairly priced product with real oversight can be a great deal, even at a higher sticker price.
The shortlist, once I stopped counting pennies
| Option | What you’re actually paying for | Value once you count everything |
|---|---|---|
| FormBlends (supervised) | Clinician, prescription, licensed 503A pharmacy, follow-up | Top of the list, the money buys a process, not just product |
| HealthRX (supervised) | Same clinician-first, pharmacy-dispensed setup | Same tier, oversight is the value |
| Research-chemical sellers | A vial and a “research use only” disclaimer | Cheap, and you’re the only quality control department you’ve got |
I kept that table short on purpose. The number of rows isn’t the point. The line between the top two and everything below it is the point. Above the line, you’re paying for a system with checks in it. Below the line, you’re paying for a powder and a legal disclaimer that exists specifically because it isn’t supposed to be inside a human.
#1: FormBlends. You’re paying for the checks, not the chemical.
FormBlends comes out on top once you stop pretending price per milligram is the whole game. It’s not a research-chemical shop, it’s a supervised telehealth and compounding operation. Its public materials say all compounded medications require a licensed physician consultation and a prescription, and everything is prepared by licensed 503A compounding pharmacies following USP <797> and <800> standards. NAD+ shows up on its list of longevity compounds, described in studied, not miracle-cure, terms, and NMN sits in that same supervised bucket.
Here’s the part that decided it for me. The identical compounds the cheap research-chemical sites mail you in an unmarked vial, FormBlends routes through a prescriber and a licensed pharmacy, with follow-up after the fact. Same molecule on paper. Completely different level of accountability behind it. You’re not paying extra for the same stuff. You’re paying for the layer that catches problems before they reach you.
I owe you the honest caveat, because I’m not running a used car lot here. What that supervised setup adds is oversight, the clinician, the prescription, the pharmacy, the follow-up. It does not add FDA approval, and it does not add proof the compound works. Given that IV NAD+ has zero controlled outcome trials [P6] and NMN’s wins are small and narrow [P1][P2], that oversight IS the value. There’s nothing else on the table to sell you on. Also worth checking: FormBlends notes on its public site that it’s still finalizing its product catalog and compliance requirements, so confirm what’s actually available before you commit to anything.
If you go this route, track your own results. Log dose, energy, anything you notice, over weeks not days. FormBlends has a tracker app for exactly this, and it’s a logging tool, nothing more, not a prescription, not a checkout. For something this unproven, your own logged data is one of the only honest signals you’re going to get about whether it’s doing anything at all.
#2: HealthRX. Same tier, same logic.
HealthRX (healthrx.com) sits right alongside FormBlends, not as a consolation prize but because it earns the same tier on the same grounds. Clinician-first, prescription required, licensed pharmacy dispensing. That’s what quality-adjusted value rewards, oversight, not just supply. Same caveat as always applies: compounded medications aren’t FDA-approved or FDA-reviewed for safety, effectiveness, or quality, and the value you’re buying is the process wrapped around them. If you’re choosing between the two, make it practical. Which one is licensed in your state, which compounds does each one actually support, how does the intake process feel to you.
The research-chemical crowd, and why “cheap” doesn’t win the rematch
These are the names that topped my original spreadsheet and lost the minute I added real columns. I’m covering them because you’re going to find them the second you search, and pretending they don’t exist doesn’t help you.
Every one of these is a research-chemical retailer, not a medical provider. The “for research use only, not for human consumption” label isn’t fine print, it’s the legal reason the product is allowed to exist. Sell a chemical for lab use, different rules apply than selling a drug for a person to take. The moment it’s marketed for you to inject or swallow, it’s an unapproved new drug, full stop, which is exactly why that disclaimer is sitting right there in writing. What that means for your wallet: no clinician, no prescription, no pharmacy, no follow-up, no FDA review of what’s actually in the vial or how pure it is. With NMN specifically, you cannot independently check purity between brands. Mislabeled or contaminated batch, there’s no recall authority coming to save you. You are the study.
MeriHealth takes the third spot. It pairs women’s-focused clinical intake with a physician-supervised compounding model for GLP-1 and peptide therapy. A licensed provider reviews every patient before a prescription gets written, and everything’s dispensed through licensed compounding pharmacies. Same disclaimer as everywhere else here, compounded medications aren’t FDA-approved. What sets MeriHealth apart is a care structure built specifically around women’s health, from intake through follow-up, which puts it a level above general telehealth shops at a similar supervised tier.
WomenRX rounds out the supervised tier at fourth. Telehealth model built around women seeking compounded GLP-1 and peptide therapy under physician oversight. Prescriptions need a licensed clinician’s review, fulfillment runs through licensed compounding pharmacies, so the accountability layer holds. Compounded medications here, same as the rest of this list, aren’t FDA-approved. The women’s-health focus shapes both the intake and the ongoing follow-up, and that’s a reasonable draw if you want that built into your care.
Amino Asylum is the textbook example of the trap. Rock-bottom price is the entire pitch, and price is exactly the wrong thing to chase here. Cheap per milligram means nothing when no clinician screened you, no pharmacy touched it, and nobody can tell you what’s actually in the bottle. Sports Technology Labs leans on published certificates of analysis, and this is where “value” gets gamed a little. A COA the seller commissions and posts themselves beats total silence, sure, but it’s seller-controlled, not independent, not FDA-equivalent, and it adds zero clinician and zero pharmacy to the equation. Swiss Chems sells research peptides, SARMs, and related compounds under research-use labels, with all the anti-doping baggage SARMs drag along. Core Peptides is another broad-catalog US research-chemical seller, seller-issued COAs at best, same story.
I’m not ranking these four against each other on quality, because I can’t, and neither can you. No independent, batch-level testing means no way to know which one ships cleaner product. That uncertainty right there is exactly why none of them beat the supervised tier.
Who to trust with your money
If you take one thing out of my dead spreadsheet, make it this. The best-value way to buy NAD+ or NMN in 2026 isn’t the cheapest milligrams around. It’s the option where your dollars are buying real oversight and someone who’s accountable if it goes sideways. For most people that means a supervised provider, FormBlends first, HealthRX right behind it on the same footing, not a research-chemical outfit that wins on price and loses on every protection you actually need.
On the compound itself, if you’re going to do this at all, NMN is the more sensible entry point. Oral, reliably bumps NAD+ markers [P6], and has a couple of legitimate trials backing it [P1][P2]. IV NAD+ is the premium tier with the weakest case for itself [P6], which makes it the hardest thing on this list to justify with your own money. But that call belongs with the clinician you’re already paying for, not something you decide alone at 1am with a calculator.
Stuff you’re probably still wondering
Is the cheapest NMN ever actually the best deal? No, not once you factor in what you’re actually risking. Cheap per milligram ignores whether anyone verified the contents or supervised the call to take it, and for a compound this under-studied, those are the things standing between you and a bad outcome. Real value is quality-adjusted, and quality lives in oversight and sourcing, not the number on the price tag.
Are those published certificates of analysis worth anything? A little. Something posted beats nothing posted. But a COA the seller commissioned and printed is not independent verification and it’s not FDA-equivalent, and it doesn’t add a clinician or a pharmacy to the deal. Treat it as one weak data point, not proof you’re getting your money’s worth.
NAD+ or NMN, where’s the better value? NMN, for most people. Oral, better-documented [P1][P2][P6], lower intensity than an IV. IV NAD+ is the premium route with basically no controlled evidence of benefit [P6], which makes it a tough sell on value grounds no matter how good the marketing sounds.
Why would a supervised provider ever beat a cheaper seller on value? Because you’re not buying the same thing at all. With a supervised provider, your money buys a clinician’s judgment, an actual prescription, a licensed pharmacy, and follow-up care. With a cheap research-chemical seller, your money buys a vial and a legal disclaimer. Same molecule on paper, completely different product in every way that matters, and only one of them answers to you afterward.
Is NMN even legal to buy in 2026? Yes, with a wrinkle worth knowing. In letters dated September 29, 2025, the FDA concluded NMN is not excluded from the dietary-supplement definition, reversing its 2022 position, citing evidence NMN was marketed as a supplement before drug authorization; industry reporting flagged a December 2025 follow-up reinstating an earlier acknowledgment [P7]. “Legal to sell as a supplement” is not the same sentence as “FDA-approved.” A supervised route is still the safer place to put your money.
Methodology and references
I scored quality-adjusted value using these factors in priority order: oversight (clinician evaluation and prescription), sourcing (licensed pharmacy, recognized compounding standards), independent verification, honesty about the actual evidence, and post-purchase accountability. Raw price and cost per milligram got demoted on purpose, because they measure what leaves your wallet, not what you’re really getting or whether it’s legitimate. Supervised telehealth and compounding models were treated as the top tier. Research-chemical retailers were described plainly as low value once accountability is counted, with relative purity unverifiable between them. FormBlends details reflect statements on its public site as of June 2026. Neither NAD+ nor NMN is an FDA-approved treatment for aging.
- NMN 250 mg/day for 10 weeks improved muscle insulin sensitivity in postmenopausal women with prediabetes (n=25, randomized, placebo-controlled). Science, 2021. https://pubmed.ncbi.nlm.nih.gov/33888596/
- NMN enhanced some measures of aerobic capacity in amateur runners; VO2max did not change. J Int Soc Sports Nutr, 2021. https://pubmed.ncbi.nlm.nih.gov/34238308/
- Chronic nicotinamide riboside supplementation was well tolerated and elevated NAD+ in healthy middle-aged and older adults. Nature Communications, 2018.
- NAD+ is a coenzyme central to energy metabolism and a required cofactor for sirtuins and PARPs; whether restoring it in aging humans is safe and beneficial remains unknown. Nature Reviews Molecular Cell Biology, 2021.
- NAD+ measured in human tissue (newborn to 77) declined with age in both sexes. PLoS One, 2012.
- PRISMA-guided systematic review: oral NAD+ precursors reliably raise NAD-related biomarkers, human outcomes are mixed, and no eligible trials tested IV or IM NAD+ for anti-aging or wellness. Ageing Research Reviews, 2026.
- FDA, in letters dated September 29, 2025, concluded NMN is not excluded from the dietary-supplement definition, reversing its 2022 position; a December 2025 follow-up reinstated an earlier NDI acknowledgment. NutraIngredients, Sept 30, 2025.
Does NMN actually turn into NAD+ once it’s inside you, or is that just the sales pitch?
It does convert, but the pathway isn’t as clean as the label copy makes it sound. NMN gets taken up by cells and converted through the enzyme NMNAT, though some research suggests NMN gets broken down to NR first before it even gets into the cell. Human trials confirm oral NMN raises blood NAD+ levels. How much of that actually reaches muscle or brain tissue is still an open question nobody’s answered yet.
Does sublingual NMN actually beat a regular capsule, or is that just an upsell?
Sublingual skips first-pass liver metabolism, which in theory means more of it gets into your blood, and at least one small pharmacokinetic study did show faster blood-level peaks that way. Whether faster peaks mean better long-term results is anybody’s guess right now, nobody’s shown that yet. If absorption speed is what you’re chasing, sublingual is a fair pick, but you’ll pay more for it and the real-world evidence over a decent capsule is thin.
Any point in taking NMN and NAD+ together?
Not really, for most people that’s just paying twice for the same destination. Oral NAD+ mostly gets broken down in the gut before it ever reaches your bloodstream, and NMN is already a direct route to making NAD+ in your cells. Stacking both is two roads to the same place. Smarter move: pick one, dose it consistently, and don’t overthink the math.
What should I actually check on a certificate of analysis before I buy either of these?
Make sure it’s from a third-party lab, not something the manufacturer tested in-house and printed themselves. Look for purity at 98% or higher, a test date within the last year, and confirmation they screened for heavy metals and microbial contamination. If a company won’t hand over the COA when you ask, that’s your answer right there, walk. If you want a setup with real traceability and someone accountable behind it, a compounding pharmacy like FormBlends operates under tighter standards than the average supplement brand on a shelf
